These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 9617344)

  • 1. Piroxicam and acarbose as chemopreventive agents for spontaneous intestinal adenomas in APC gene 1309 knockout mice.
    Quesada CF; Kimata H; Mori M; Nishimura M; Tsuneyoshi T; Baba S
    Jpn J Cancer Res; 1998 Apr; 89(4):392-6. PubMed ID: 9617344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemopreventive efficacy of combined piroxicam and difluoromethylornithine treatment of Apc mutant Min mouse adenomas, and selective toxicity against Apc mutant embryos.
    Jacoby RF; Cole CE; Tutsch K; Newton MA; Kelloff G; Hawk ET; Lubet RA
    Cancer Res; 2000 Apr; 60(7):1864-70. PubMed ID: 10766173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoprevention of intestinal adenomas in the ApcMin mouse by piroxicam: kinetics, strain effects and resistance to chemosuppression.
    Ritland SR; Gendler SJ
    Carcinogenesis; 1999 Jan; 20(1):51-8. PubMed ID: 9934849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoprevention of spontaneous intestinal adenomas in the Apc Min mouse model by the nonsteroidal anti-inflammatory drug piroxicam.
    Jacoby RF; Marshall DJ; Newton MA; Novakovic K; Tutsch K; Cole CE; Lubet RA; Kelloff GJ; Verma A; Moser AR; Dove WF
    Cancer Res; 1996 Feb; 56(4):710-4. PubMed ID: 8631000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemoprevention of intestinal polyposis in the Apcdelta716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor.
    Oshima M; Murai N; Kargman S; Arguello M; Luk P; Kwong E; Taketo MM; Evans JF
    Cancer Res; 2001 Feb; 61(4):1733-40. PubMed ID: 11245490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Piroxicam-induced regression of intestinal adenomatous polyps in APC(delta474) mice.
    Qiu ZF; Maruyama K; Sunayama K; Kashiwabara H; Shoji T; Nakamura T; Suzuki S; Konno H; Nakamura S
    J Invest Surg; 2003; 16(2):71-81. PubMed ID: 12746190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of intestinal polyps in Msh2-deficient and non-Msh2-deficient multiple intestinal neoplasia mice by a specific cyclooxygenase-2 inhibitor and by a dual cyclooxygenase-1/2 inhibitor.
    Lal G; Ash C; Hay K; Redston M; Kwong E; Hancock B; Mak T; Kargman S; Evans JF; Gallinger S
    Cancer Res; 2001 Aug; 61(16):6131-6. PubMed ID: 11507063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of 5-aminosalicylic acid (5-ASA) for cancer chemoprevention: lack of efficacy against nascent adenomatous polyps in the Apc(Min) mouse.
    Ritland SR; Leighton JA; Hirsch RE; Morrow JD; Weaver AL; Gendler SJ
    Clin Cancer Res; 1999 Apr; 5(4):855-63. PubMed ID: 10213222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of intestinal adenoma formation in APC(Min/+) mice by Riccardin D, a natural product derived from liverwort plant Dumortiera hirsuta.
    Liu HP; Gao ZH; Cui SX; Sun DF; Wang Y; Zhao CR; Lou HX; Qu XJ
    PLoS One; 2012; 7(3):e33243. PubMed ID: 22432006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis.
    Jacoby RF; Seibert K; Cole CE; Kelloff G; Lubet RA
    Cancer Res; 2000 Sep; 60(18):5040-4. PubMed ID: 11016626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic modulation of the retinoid X receptor alpha by green tea in the azoxymethane-Apc Min/+ mouse model of intestinal cancer.
    Volate SR; Muga SJ; Issa AY; Nitcheva D; Smith T; Wargovich MJ
    Mol Carcinog; 2009 Oct; 48(10):920-33. PubMed ID: 19378291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostaglandin E(2) protects intestinal tumors from nonsteroidal anti-inflammatory drug-induced regression in Apc(Min/+) mice.
    Hansen-Petrik MB; McEntee MF; Jull B; Shi H; Zemel MB; Whelan J
    Cancer Res; 2002 Jan; 62(2):403-8. PubMed ID: 11809688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumorigenesis in the multiple intestinal neoplasia mouse: redundancy of negative regulators and specificity of modifiers.
    Halberg RB; Katzung DS; Hoff PD; Moser AR; Cole CE; Lubet RA; Donehower LA; Jacoby RF; Dove WF
    Proc Natl Acad Sci U S A; 2000 Mar; 97(7):3461-6. PubMed ID: 10716720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoprevention of spontaneous intestinal adenomas in the adenomatous polyposis coli Min mouse model with aspirin.
    Barnes CJ; Lee M
    Gastroenterology; 1998 May; 114(5):873-7. PubMed ID: 9558273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-related difference in susceptibility of Apc(Min/+) mice towards the chemopreventive efficacy of dietary aspirin and curcumin.
    Perkins S; Clarke AR; Steward W; Gescher A
    Br J Cancer; 2003 May; 88(9):1480-3. PubMed ID: 12778080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. R-flurbiprofen chemoprevention and treatment of intestinal adenomas in the APC(Min)/+ mouse model: implications for prophylaxis and treatment of colon cancer.
    Wechter WJ; Kantoci D; Murray ED; Quiggle DD; Leipold DD; Gibson KM; McCracken JD
    Cancer Res; 1997 Oct; 57(19):4316-24. PubMed ID: 9331093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sodium taurocholate inhibits intestinal adenoma formation in APCMin/+ mice, potentially through activation of the farnesoid X receptor.
    Smith DL; Keshavan P; Avissar U; Ahmed K; Zucker SD
    Carcinogenesis; 2010 Jun; 31(6):1100-9. PubMed ID: 20194350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary intake of rosmarinic acid by Apc(Min) mice, a model of colorectal carcinogenesis: levels of parent agent in the target tissue and effect on adenoma development.
    Karmokar A; Marczylo TH; Cai H; Steward WP; Gescher AJ; Brown K
    Mol Nutr Food Res; 2012 May; 56(5):775-83. PubMed ID: 22648624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemopreventive efficacy and pharmacokinetics of curcumin in the min/+ mouse, a model of familial adenomatous polyposis.
    Perkins S; Verschoyle RD; Hill K; Parveen I; Threadgill MD; Sharma RA; Williams ML; Steward WP; Gescher AJ
    Cancer Epidemiol Biomarkers Prev; 2002 Jun; 11(6):535-40. PubMed ID: 12050094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoprevention of colon and small intestinal tumorigenesis in APC(Min/+) mice by licofelone, a novel dual 5-LOX/COX inhibitor: potential implications for human colon cancer prevention.
    Mohammed A; Janakiram NB; Li Q; Choi CI; Zhang Y; Steele VE; Rao CV
    Cancer Prev Res (Phila); 2011 Dec; 4(12):2015-26. PubMed ID: 21885812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.